Amphastar Pharmaceuticals, Inc. develops, manufactures, and commercializes injectable and inhalation pharmaceutical products, with a portfolio that includes both branded and generic medicines. The company also performs contract manufacturing services and has built capabilities across finished dosage forms, APIs, and certain starting materials. Its business is centered on complex sterile and specialty products such as glucagon, epinephrine, phytonadione, and BAQSIMI®, alongside development-stage candidates. Amphastar operates as a single reportable segment, pharmaceutical products, and relies on a mix of U.S. and China manufacturing assets to support supply and future pipeline expansion.
23,9 %
49,5 %
13,6 %
−1,7 %
4.02
2.90
| % | |
|---|---|
| Branded pharmaceutical products | 55% Commercial branded medicines such as BAQSIMI®, glucagon, epinephrine, Primatene MIST®, and phytonadione. |
| Generic injectable products | 25% Sterile injectable medicines sold into hospital and retail channels, including products like enoxaparin and nitroprusside. |
| Inhalation products | 8% Respiratory products sold through pharmacy and healthcare distribution channels. |
| Contract manufacturing services | 7% Third-party manufacturing services recognized when products are shipped to customers. |
| APIs and starting materials | 5% Internal and external supply of APIs, intermediates, and starting materials used in finished products and pipeline manufacturing. |
Amphastar sells primarily to wholesalers and distributors that then supply pharmacies, hospitals, and other end...
Buy finished products in bulk for redistribution and are central to Amphastar's U.S. commercial model because they manage inventory, chargebacks, and downstream fulfillment.
Purchase injectable medicines used in acute care and procedural settings, where product availability and regulatory compliance matter.
Buys branded and OTC-adjacent products such as Primatene MIST® and BAQSIMI® for patient dispensing.
Use Amphastar's manufacturing capabilities for contract development and manufacturing services.
Influence demand for prescription products through coverage, co-pay support, and formulary access even though they are not direct purchasers.
Amphastar is headquartered in the United States and generates most of its business through U.S...
Amphastar is focused on expanding its injectable and inhalation platform while integrating BAQSIMI® globally into its...
Capacity, supply reliability, and cost control are central to a sterile injectable business with regulatory oversight and import exposure.
BAQSIMI® adds branded revenue and can improve mix, but requires successful commercialization and milestone management.
New launches are needed to offset product-level volatility and support longer-term growth.
Acquisitions can add technologies, manufacturing know-how, and commercial assets faster than organic development alone.
Amphastar faces meaningful concentration and execution risk around a relatively small set of commercial products, where...
A portion of manufacturing takes place in China, including starting materials and APIs for several products, so plant disruption or political/trade changes could interrupt supply and raise costs.
Management noted that glucagon, epinephrine, and other products can fluctuate based on competitive dynamics and competitor supply, which can quickly affect revenue mix.
FDA and DEA oversight of formulation, manufacture, distribution, packaging, and labeling means any compliance issue can disrupt production or trigger remediation costs.
The company imports APIs, starting materials, and components from various countries, so tariffs or trade restrictions can increase input costs and complicate sourcing.
A security incident could disrupt operations, compromise clinical or commercial data, and create legal and reputational harm.
ABSI · Services-Commercial Physical & Biological Research
Absci Corp is a biotechnology company built around its Integrated Drug Creation platform, which combines AI-driven design, wet-lab biology, and computational…
AMRX · Pharmaceutical Preparations
Amneal Pharmaceuticals is a U.S.-based diversified biopharmaceutical company that develops, manufactures, markets, and distributes essential medicines across…
AP · Pumps & Pumping Equipment
WST · Surgical & Medical Instruments & Apparatus
West Pharmaceutical Services is a U.S.-based manufacturer of containment and delivery systems used with injectable drugs and healthcare products.
ABCL · Pharmaceutical Preparations
AMBQ · Semiconductors & Related Devices
: 11/08/2026